Author Question: Why are calcium-channel blockers not used in all patients with idiopathic pulmonary artery ... (Read 85 times)

jparksx

  • Hero Member
  • *****
  • Posts: 570
Why are calcium-channel blockers not used in all patients with idiopathic pulmonary artery hy-pertension?
 
  a. It causes severe side effects.
  b. Many of these patients have systemic hy-potension.
  c. Only a small percentage of IPAH patients respond.
  d. There is a high incidence of anaphylaxis.

Question 2

In what type of IPAH patient is lung transplantation indicated?
 
  a. All pulmonary artery hypertension patients with clinically significant disease
  b. Patients not responding to vasodilators with significant cardiac dysfunction
  c. Patients with class II, class III, or class IV disease
  d. Patients with refractory hypoxemia



Expo

  • Sr. Member
  • ****
  • Posts: 351
Answer to Question 1

ANS: C
Patients with IPAH who respond to vasodilators in the short term have improved survival with long-term use of calcium-channel blockers. Thus, these agents should be considered in all patients who have significant and definite response to a short-acting vasodilator. Unfortunately, only a small fraction of IPAH patients qualify for and benefit from long-term therapy with oral calci-um-channel blockers.

Answer to Question 2

ANS: B
Single or double lung transplantation has been used successfully in the treatment of patients with IPAH. Lung transplantation is indicated in the care of patients who do not respond to vasodila-tors and have significant cardiac impairment.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

To combat osteoporosis, changes in lifestyle and diet are recommended. At-risk patients should include 1,200 to 1,500 mg of calcium daily either via dietary means or with supplements.

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

It is believed that humans initially contracted crabs from gorillas about 3 million years ago from either sleeping in gorilla nests or eating the apes.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...

For a complete list of videos, visit our video library